Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities
Concept Life Sciences (CLS), a leading integrated drug discovery, development, and manufacturing organisation backed by Limerston Capital, today announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors. CLS is pleased to welcome Professor Luke O’Neill, and Dr. Shane Liddelow to its Scientific Advisory Board (SAB), while […]
Continue Reading